stars 1 stars 2 stars 3

Biocytogen provides integrated solutions for next-generation antibody drug development to the global biomedical communities. Powered by cutting-edge gene editing technologies and a state-of-the-art animal facility, Biocytogen developed a seamlessly integrated platform for efficient antibody drug discovery and validation, including animal model generation, therapeutic antibody discovery (via RenMabâ„¢ mice), and in vivo/in vitro preclinical validation studies. Biocytogen collaborates with more than 70% of the top 50 pharmaceutical and biotechnology companies worldwide. Together, we discover innovative medicines for a better, healthier world.

Biocytogen Questions

The Biocytogen annual revenue was $488.8 million in 2026.

Madeline Lee is the COO of Biocytogen.

158 people are employed at Biocytogen.

Biocytogen is based in Waltham, Massachusetts.

The NAICS codes for Biocytogen are [54, 5417, 54171, 541, 541714].

The SIC codes for Biocytogen are [87, 873].

Top Biocytogen Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users